CN102329263A - Preparation method of N-acetyl-5-methoxytryptamine - Google Patents
Preparation method of N-acetyl-5-methoxytryptamine Download PDFInfo
- Publication number
- CN102329263A CN102329263A CN201110314476A CN201110314476A CN102329263A CN 102329263 A CN102329263 A CN 102329263A CN 201110314476 A CN201110314476 A CN 201110314476A CN 201110314476 A CN201110314476 A CN 201110314476A CN 102329263 A CN102329263 A CN 102329263A
- Authority
- CN
- China
- Prior art keywords
- methoxytryptamine
- preparation
- add
- reaction
- dichloromethane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明公开了一种N-乙酰基-5-甲氧基色胺的制备方法。将原料5-甲氧基色胺加入二氯甲烷溶剂中,5-10℃下,0.5-1.0小时滴加乙酸酐与二氯甲烷的混合液,加入催化剂4-DMAP,常温下反应1-2小时,从反应产物中收集目标产物。经检测,产物纯度≥98%,产率≥94%,熔点114-117℃。本发明采用催化剂4-DMAP进行N-酰化反应,用量少,速度快,副反应少,反应条件温和,收率高,反应在常压下进行,操作安全简便,适于工业化生产。The invention discloses a preparation method of N-acetyl-5-methoxytryptamine. Add the raw material 5-methoxytryptamine into the dichloromethane solvent, add the mixture of acetic anhydride and dichloromethane dropwise for 0.5-1.0 hours at 5-10°C, add the catalyst 4-DMAP, and react at room temperature for 1-2 hours , to collect the target product from the reaction product. After testing, the purity of the product is ≥98%, the yield is ≥94%, and the melting point is 114-117°C. The present invention adopts the catalyst 4-DMAP to carry out N-acylation reaction, and the dosage is small, the speed is fast, the side reaction is less, the reaction condition is mild, the yield is high, the reaction is carried out under normal pressure, the operation is safe and convenient, and it is suitable for industrial production.
Description
技术领域 technical field
本发明涉及一种N-乙酰基-5-甲氧基色胺的制备方法,具体涉及一种采用催化剂4-二甲氨基吡啶(4-DMAP)来合成N-乙酰基-5-甲氧基色胺的制备方法。The invention relates to a preparation method of N-acetyl-5-methoxytryptamine, in particular to a method for synthesizing N-acetyl-5-methoxytryptamine by using catalyst 4-dimethylaminopyridine (4-DMAP) method of preparation.
背景技术 Background technique
N-乙酰基-5-甲氧基色胺又称褪黑激素,英文名Melatonin(MLT)。N-乙酰基-5-甲氧基色胺是一种主要由松果体所分泌的多肽类激素,研究表明,临床上可以调节生物节律,治疗失眠,改善睡眠质量,调节人体的免疫功能,清除人体内的自由基,同时还可以防止肿瘤化疗药物对造血功能的毒性作用,在治疗多种中枢神经系统疾病方面有着广阔的应用前景。N-acetyl-5-methoxytryptamine is also called melatonin, and its English name is Melatonin (MLT). N-acetyl-5-methoxytryptamine is a polypeptide hormone mainly secreted by the pineal gland. Studies have shown that clinically it can regulate biological rhythms, treat insomnia, improve sleep quality, regulate the body's immune function, clear Free radicals in the human body can also prevent the toxic effect of tumor chemotherapy drugs on hematopoietic function, and have broad application prospects in the treatment of various central nervous system diseases.
其结构式如下:Its structural formula is as follows:
现有技术中,曹会兰报道了一种用吲哚制备N-乙酰基-5-甲氧基色胺的方法【褪黑素的合成方法,应用化工,2001,Vol.No.5,5-6】。其以吲哚为原料进行羟基化、氨乙基化、甲基化,然后与乙酸酐通过酰化反应制得目标产物N-乙酰基-5-甲氧基色胺。但是由于其工艺操作繁琐,成本高,收率较低,总收率小于22%,因此,工业化前景不理想。In the prior art, Cao Huilan reported a method for preparing N-acetyl-5-methoxytryptamine from indole [Synthetic Method of Melatonin, Applied Chemical Industry, 2001, Vol.No.5, 5-6] . It uses indole as a raw material to carry out hydroxylation, aminoethylation, and methylation, and then reacts with acetic anhydride to obtain the target product N-acetyl-5-methoxytryptamine through acylation reaction. But because its technological operation is loaded down with trivial details, and cost is high, and yield is low, and total yield is less than 22%, and therefore, industrialization prospect is unsatisfactory.
杨建武等报道了一种以5-甲氧基色胺为原料,二氯甲烷为溶剂,乙酸酐为酰化试剂进行反应合成N-乙酰基-5-甲氧基色胺的方法【化学研究”2003,14(4):42-44】。但是由于该方法未使用催化剂,酰化反应时间需3小时左右,反应速度较慢,且收率仅为80%,因此耗能大、成本高。Yang Jianwu et al reported a method for the synthesis of N-acetyl-5-methoxytryptamine using 5-methoxytryptamine as a raw material, dichloromethane as a solvent, and acetic anhydride as an acylating reagent [Chemical Research, 2003, 14(4):42-44]. However, since no catalyst is used in this method, the acylation reaction takes about 3 hours, the reaction speed is relatively slow, and the yield is only 80%, so the energy consumption is large and the cost is high.
发明内容 Contents of the invention
本发明所要解决的技术问题在于提供一种N-乙酰基-5-甲氧基色胺的制备方法,采用催化剂4-二甲氨基吡啶,克服了现有技术中操作繁琐、成本高、收率低、反应速度慢等不足。The technical problem to be solved by the present invention is to provide a preparation method of N-acetyl-5-methoxytryptamine, using catalyst 4-dimethylaminopyridine, which overcomes the complicated operation, high cost and low yield in the prior art , slow response and other deficiencies.
本发明的技术构思是这样的:Technical concept of the present invention is such:
以5-甲氧基色胺为原料,在二氯甲烷溶剂中,与酰化试剂乙酸酐反应,常温,在催化剂4-DMAP的作用下进行N-酰化,从而可以在常压下制得N-乙酰基-5-甲氧基色胺。Using 5-methoxytryptamine as a raw material, react with the acylating agent acetic anhydride in dichloromethane solvent, and carry out N-acylation under the action of catalyst 4-DMAP at room temperature, so that N - Acetyl-5-methoxytryptamine.
本发明所述的N-乙酰基-5-甲氧基色胺的制备方法,包括以下步骤:The preparation method of N-acetyl-5-methoxytryptamine of the present invention comprises the following steps:
将5-甲氧基色胺加入二氯甲烷溶剂中,5-10℃下0.5-1.0小时内滴加乙酸酐与二氯甲烷的混合液,加入催化剂4-DMAP,常温下反应1-2小时,从反应产物中收集目标产物N-乙酰基-5-甲氧基色胺。Add 5-methoxytryptamine into the dichloromethane solvent, add the mixture of acetic anhydride and dichloromethane dropwise within 0.5-1.0 hours at 5-10°C, add the catalyst 4-DMAP, and react at room temperature for 1-2 hours, The target product N-acetyl-5-methoxytryptamine was collected from the reaction product.
反应式如下:The reaction formula is as follows:
按照本发明,所述5-甲氧基色胺与二氯甲烷的质量体积比为1∶5-10,g/ml。According to the present invention, the mass volume ratio of the 5-methoxytryptamine to dichloromethane is 1:5-10, g/ml.
所述5-甲氧基色胺与乙酸酐的摩尔比为1∶1-1.05,mol/mol。The molar ratio of the 5-methoxytryptamine to acetic anhydride is 1:1-1.05, mol/mol.
所述乙酸酐与二氯甲烷的混合液是以1∶2-3,ml/ml的体积比配制而成。The mixed solution of acetic anhydride and dichloromethane is prepared at a volume ratio of 1:2-3, ml/ml.
所述5-甲氧基色胺与催化剂4-DMAP的质量比为1∶0.03-0.06,g/g。The mass ratio of the 5-methoxytryptamine to the catalyst 4-DMAP is 1:0.03-0.06, g/g.
本发明从反应产物中收集目标产物包括如下步骤:反应液用NaOH溶液进行中和,水洗至中性,得到的有机相用活性炭脱色,减压蒸出二氯甲烷溶剂(回收后循环使用),浓缩液在4℃以下析出白色晶体,经过滤,干燥后得到目标产物。The present invention collects the target product from the reaction product and comprises the following steps: the reaction solution is neutralized with NaOH solution, washed to neutrality, the obtained organic phase is decolorized with activated carbon, dichloromethane solvent is evaporated under reduced pressure (recycled after recovery), The concentrated solution precipitated white crystals below 4°C, and was filtered and dried to obtain the target product.
其中,所述5-甲氧基色胺与NaOH的摩尔比为1∶1-1.05,mol/mol。所述5-甲氧基色胺与活性炭的质量比为1∶0.02-0.05,g/g。Wherein, the molar ratio of 5-methoxytryptamine to NaOH is 1:1-1.05, mol/mol. The mass ratio of the 5-methoxytryptamine to the activated carbon is 1:0.02-0.05, g/g.
用本发明方法得到的N-乙酰基-5-甲氧基色胺,纯度≥98%,收率≥94%,熔点114-117℃。The N-acetyl-5-methoxytryptamine obtained by the method of the present invention has a purity of ≥98%, a yield of ≥94%, and a melting point of 114-117°C.
有益效果:Beneficial effect:
本发明以4-DMAP为催化剂进行N-酰化反应,用量少,速度快,副反应少,反应条件温和,收率高,反应在常压下进行,操作安全简便,适于工业化生产。The invention uses 4-DMAP as a catalyst to carry out N-acylation reaction, which has the advantages of less consumption, high speed, less side reactions, mild reaction conditions, high yield, reaction under normal pressure, safe and convenient operation, and is suitable for industrial production.
具体实施方式 Detailed ways
下面通过实施例对本发明作进一步说明,但实施例并不限制本发明的保护范围。The present invention will be further described below by the examples, but the examples do not limit the protection scope of the present invention.
实施例1Example 1
在带有低温恒温反应浴、搅拌、温度计的反应器中分别加入38.05g(0.2mol)5-甲氧基色胺、200ml二氯甲烷,搅拌下,保持反应温度5-10℃,0.5小时内滴入含20.4g(0.2mol)乙酸酐、二氯甲烷溶剂的混合液(按乙酸酐∶二氯甲烷=1∶2的体积比配制),加入1.2g 4-DMAP,常温下反应2小时。Add 38.05g (0.2mol) of 5-methoxytryptamine and 200ml of dichloromethane to a reactor equipped with a low-temperature and constant-temperature reaction bath, stirring, and a thermometer respectively. Under stirring, keep the reaction temperature at 5-10°C and drop in 0.5 hours Add 20.4g (0.2mol) of acetic anhydride and a mixed solution of dichloromethane solvent (prepared according to the volume ratio of acetic anhydride:dichloromethane=1:2), add 1.2g 4-DMAP, and react at room temperature for 2 hours.
向反应液中加入200ml 1mol/L NaOH溶液中和,水洗至中性,向分出的有机相中加入1.0g活性炭进行脱色,减压下蒸出二氯甲烷溶剂(回收后循环使用),浓缩液在4℃以下析出白色晶体,经过滤、干燥后,即得到目标产物N-乙酰基-5-甲氧基色胺43.6g,收率94%,纯度98.7%(HPLC),熔点114-117℃。Add 200ml of 1mol/L NaOH solution to the reaction solution for neutralization, wash with water until neutral, add 1.0g of activated carbon to the separated organic phase for decolorization, distill out the dichloromethane solvent under reduced pressure (recycled after recovery), concentrate White crystals precipitated from the solution below 4°C, and after filtration and drying, 43.6 g of the target product N-acetyl-5-methoxytryptamine was obtained, with a yield of 94%, a purity of 98.7% (HPLC), and a melting point of 114-117°C .
实施例2Example 2
在带有低温恒温反应浴、搅拌、温度计的反应器中分别加入38.05g(0.2mol)5-甲氧基色胺、300ml二氯甲烷,搅拌下,保持反应温度5-10℃,0.5小时内滴入含21.44g(0.21mol)乙酸酐、二氯甲烷溶剂的混合液(按乙酸酐∶二氯甲烷=1∶3的体积比配制),加入2.0g 4-DMAP,常温下反应2小时。Add 38.05g (0.2mol) of 5-methoxytryptamine and 300ml of dichloromethane to a reactor equipped with a low-temperature and constant-temperature reaction bath, stirring, and a thermometer respectively. Under stirring, keep the reaction temperature at 5-10°C and drop in 0.5 hours Add 21.44g (0.21mol) of acetic anhydride and a mixed solution of dichloromethane solvent (prepared according to the volume ratio of acetic anhydride:dichloromethane=1:3), add 2.0g 4-DMAP, and react at room temperature for 2 hours.
向反应液中加入210ml 1mol/L NaOH溶液中和,水洗至中性,分出的有机相中加入1.8g活性炭进行脱色,减压下蒸出二氯甲烷溶剂(回收后循环使用),浓缩液在4℃以下析出白色晶体,经过滤、干燥后,即得到目标产物N-乙酰基-5-甲氧基色胺44.4g,收率95%,纯度98.3%(HPLC),熔点114-117℃。Add 210ml 1mol/L NaOH solution to the reaction solution to neutralize, wash with water to neutrality, add 1.8g gac to decolorize in the separated organic phase, dichloromethane solvent is distilled off under reduced pressure (recycling after recovery), concentrated solution White crystals precipitated below 4°C. After filtration and drying, 44.4 g of the target product N-acetyl-5-methoxytryptamine was obtained, with a yield of 95%, a purity of 98.3% (HPLC), and a melting point of 114-117°C.
需要说明的是,以上实施例仅用以说明本发明的技术方案而非限制。尽管参照较佳实施例对本发明进行了详细说明,本领域的普通技术人员应当理解,可以对发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的范围,其均应涵盖在本发明的权利要求范围中。It should be noted that the above embodiments are only used to illustrate the technical solution of the present invention and not to limit. Although the present invention has been described in detail with reference to preferred embodiments, those skilled in the art should understand that the technical solution of the invention can be modified or equivalently replaced without departing from the scope of the technical solution of the present invention, which should be covered in this within the scope of the claimed invention.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110314476A CN102329263A (en) | 2011-10-17 | 2011-10-17 | Preparation method of N-acetyl-5-methoxytryptamine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110314476A CN102329263A (en) | 2011-10-17 | 2011-10-17 | Preparation method of N-acetyl-5-methoxytryptamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102329263A true CN102329263A (en) | 2012-01-25 |
Family
ID=45481253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110314476A Pending CN102329263A (en) | 2011-10-17 | 2011-10-17 | Preparation method of N-acetyl-5-methoxytryptamine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102329263A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104496882A (en) * | 2014-11-29 | 2015-04-08 | 湖北金赛药业有限公司 | Synthesis method of melatonin |
| CN106622070A (en) * | 2016-12-26 | 2017-05-10 | 武汉工程大学 | Method for continuously preparing melatonin by using microreactor |
| CN110105261A (en) * | 2018-12-24 | 2019-08-09 | 武汉工程大学 | A method of continuous, rapid synthesis and purification epiphysin using microreactor |
| CN113788780A (en) * | 2021-10-15 | 2021-12-14 | 河北维达康生物科技有限公司 | A kind of synthetic method of N-acetyl-5-methoxytryptamine |
| CN114085179A (en) * | 2021-11-29 | 2022-02-25 | 福建科宏生物工程股份有限公司 | Preparation method of N-acetyl-5-methoxytryptamine |
| CN114150027A (en) * | 2021-12-03 | 2022-03-08 | 河北维达康生物科技有限公司 | Method for synthesizing N-acetyl-5-methoxytryptamine by using 5-hydroxy beta-indolylalanine as substrate through biological method |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1932831A1 (en) * | 2006-12-13 | 2008-06-18 | Bayer Schering Pharma Aktiengesellschaft | 1,2-Diarylacetylene Derivatives of Acyltryptophanols |
| CN101362715A (en) * | 2007-08-07 | 2009-02-11 | 江卫世 | Preparation method of n-acetyl-5-methoxytryptamine |
| WO2011047156A1 (en) * | 2009-10-15 | 2011-04-21 | Hercules Technology Management Co V, Inc. | Sepiapterin reductase inhibitors for the treatment of pain |
-
2011
- 2011-10-17 CN CN201110314476A patent/CN102329263A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1932831A1 (en) * | 2006-12-13 | 2008-06-18 | Bayer Schering Pharma Aktiengesellschaft | 1,2-Diarylacetylene Derivatives of Acyltryptophanols |
| CN101362715A (en) * | 2007-08-07 | 2009-02-11 | 江卫世 | Preparation method of n-acetyl-5-methoxytryptamine |
| WO2011047156A1 (en) * | 2009-10-15 | 2011-04-21 | Hercules Technology Management Co V, Inc. | Sepiapterin reductase inhibitors for the treatment of pain |
Non-Patent Citations (1)
| Title |
|---|
| 陆国元: "《有机反应与有机合成》", 30 June 2009 * |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104496882A (en) * | 2014-11-29 | 2015-04-08 | 湖北金赛药业有限公司 | Synthesis method of melatonin |
| CN106622070A (en) * | 2016-12-26 | 2017-05-10 | 武汉工程大学 | Method for continuously preparing melatonin by using microreactor |
| CN110105261A (en) * | 2018-12-24 | 2019-08-09 | 武汉工程大学 | A method of continuous, rapid synthesis and purification epiphysin using microreactor |
| CN113788780A (en) * | 2021-10-15 | 2021-12-14 | 河北维达康生物科技有限公司 | A kind of synthetic method of N-acetyl-5-methoxytryptamine |
| CN113788780B (en) * | 2021-10-15 | 2023-06-16 | 河北维达康生物科技有限公司 | Synthesis method of N-acetyl-5-methoxy tryptamine |
| CN114085179A (en) * | 2021-11-29 | 2022-02-25 | 福建科宏生物工程股份有限公司 | Preparation method of N-acetyl-5-methoxytryptamine |
| CN114085179B (en) * | 2021-11-29 | 2024-05-03 | 福建科宏生物工程股份有限公司 | A preparation method of N-acetyl-5-methoxytryptamine |
| CN114150027A (en) * | 2021-12-03 | 2022-03-08 | 河北维达康生物科技有限公司 | Method for synthesizing N-acetyl-5-methoxytryptamine by using 5-hydroxy beta-indolylalanine as substrate through biological method |
| CN114150027B (en) * | 2021-12-03 | 2025-10-10 | 河北维达康生物科技有限公司 | Method for biosynthesizing N-acetyl-5-methoxytryptamine using 5-hydroxy-β-indolylalanine as substrate |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113214133B (en) | A kind of synthetic method of melatonin | |
| CN103058989B (en) | A kind of preparation method of α-lipoic acid | |
| CN102329263A (en) | Preparation method of N-acetyl-5-methoxytryptamine | |
| CN103571907B (en) | A kind of separation of enzymatic clarification cefaclor and purification process | |
| CN102101847B (en) | Method for preparing N-methyl-N'-(2-chloroethyl)piperazine | |
| CN110698474B (en) | A kind of α-position substituted tetrahydro-γ-carboline compound and preparation method and application thereof | |
| CN104045669A (en) | Separation method suitable for chemical synthesis of salidroside for industrial production | |
| CN102317256B (en) | Process for preparing racecadotril | |
| CN110078695B (en) | A kind of quercetin derivative and preparation method thereof | |
| CN107304186B (en) | Refining method of olaparib | |
| CN107501238A (en) | A kind of process for purification of Rabeprazole | |
| CN115677456B (en) | Preparation method of cannabidiol | |
| WO2021212535A1 (en) | Method for refining benzhexol hydrochloride | |
| CN106749098B (en) | A kind of preparation method preparing dioxopromethazine hydrochloride using oxygen as oxidant | |
| CN110305067A (en) | A kind of optimum synthesis technique of anticancer drug Dacarbazine | |
| CN104311518A (en) | Preparation method for 6-methoxyscutellarin | |
| CN104529812A (en) | Method for preparing propitocaine hydrochloride | |
| CN108586564B (en) | A C5-substituted diosgenin derivative and its preparation and application | |
| CN103224489B (en) | Method for enhancing production yield and rate of esomeprazole | |
| CN112457235B (en) | Preparation method of 7-methylindole | |
| CN104478851A (en) | Method for preparing articaine hydrochloride | |
| CN110642770B (en) | Preparation method of 5-methoxyindole | |
| CN102964310A (en) | Preparation method of 2-position substituted imidazole | |
| CN110183371A (en) | A kind of preparation process of zafirlukast intermediate | |
| CN108329313A (en) | A method of synthesis pyrroloquinoline quinone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C05 | Deemed withdrawal (patent law before 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120125 |

